ORAL AND PARENTERAL FORMULATIONS OF MARIHUANA CONSTITUENTS

被引：36

|

作者：

ROSENKRANTZ, H

THOMPSON, GR

BRAUDE, MC

机构：

来源：

JOURNAL OF PHARMACEUTICAL SCIENCES | 1972年 / 61卷 / 07期

关键词：

D O I：

10.1002/jps.2600610715

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

引用

收藏

页码：1106 / +

页数：1

相关论文

共 50 条

[1] BIOAVAILABILITY OF ORAL AND PARENTERAL FORMULATIONS OF LEUCOVORIN
LASSETER, KC
SHAMBLEN, E
WOODWARD, D
STOKSTADT, E
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1983, 33 (02) : 222 - 222
[2] Fatty acids as therapeutic auxiliaries for oral and parenteral formulations
Hackett, Michael J.
Zaro, Jennica L.
Shen, Wei-Chiang
Guley, Patrick C.
Cho, Moo J.
ADVANCED DRUG DELIVERY REVIEWS, 2013, 65 (10) : 1331 - 1339
[3] METABOLISM AND PHARMACOLOGY OF MARIHUANA CONSTITUENTS
YAMAMOTO, I
YOSHIMURA, H
EISEI KAGAKU-JAPANESE JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH, 1982, 28 (05): : 233 - 248
[4] TOLERANCE TO ACTIVE CONSTITUENTS OF MARIHUANA
MCMILLAN, DE
HARRIS, LS
HARRIS, RA
FRANKENHEIM, JM
FORD, RD
ARCHIVES INTERNATIONALES DE PHARMACODYNAMIE ET DE THERAPIE, 1972, 198 (01): : 132 - +
[5] Polyethylene glycols in oral and parenteral formulations-A critical review
Gullapalli, Rampurna P.
Mazzitelli, Carolyn L.
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2015, 496 (02) : 219 - 239
[6] Parenteral formulations
Holm, Rene
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2024, 200
[7] IMMUNOSUPPRESSION BY MARIHUANA AND ITS CANNABINOID CONSTITUENTS
LEVY, JA
HEPPNER, GH
JOURNAL OF IMMUNOPHARMACOLOGY, 1980, 2 (02): : 159 - 177
[8] DISCRIMINABLE STIMULI PRODUCED BY MARIHUANA CONSTITUENTS
KRIMMER, EC
BARRY, H
PSYCHOPHARMACOLOGY COMMUNICATIONS, 1976, 2 (04) : 319 - 322
[9] PHOTOCHEMICAL STUDIES OF MARIHUANA (CANNABIS) CONSTITUENTS
ALLWARDT, WH
BABCOCK, PA
CROSS, JM
SEGELMAN, AB
JOURNAL OF PHARMACEUTICAL SCIENCES, 1972, 61 (12) : 1994 - &
[10] CLINICAL PHARMACOLOGICAL STUDIES OF MARIHUANA CONSTITUENTS
HOLLISTER, LE
PROCEEDINGS OF THE WESTERN PHARMACOLOGY SOCIETY, 1971, 14 : 26 - +

← 1 2 3 4 5 →